Stonebridge Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Sell
4,884
-72
-1% -$18.5K 0.16% 89
2026
Q2
$1.25M Buy
+4,956
New +$1.07M 0.17% 92

Other funds holding ABBV

Stonebridge Financial Group's ABBV Position: Q3 2026 in Review

Stonebridge Financial Group reduced its AbbVie (ABBV) stake by 1.5% in Q3 2026, selling an estimated $18.5K and leaving 4,884 shares worth $1.28M. The position accounts for 0.16% of the portfolio, ranked #89.

Stonebridge Financial Group first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Stonebridge Financial Group held 4,884 shares of AbbVie worth $1.28M as of Q3 2026.
  • Stonebridge Financial Group sold 72 AbbVie shares in Q3 2026, an estimated $18.5K.
  • AbbVie made up 0.16% of Stonebridge Financial Group's portfolio in Q3 2026, its #89 holding.
  • Stonebridge Financial Group first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Stonebridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.